Systemic management of diabetic retinopathy

被引：4

作者：

Liew, Gerald ^{[1
]}

Mitchell, Paul ^{[1
]}

Wong, Tien Y. ^{[2
]}

机构：

[1] Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia

[2] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 168751, Singapore

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2009年 / 338卷

关键词：

PROGRESSION; GLUCOSE; CANDESARTAN; OUTCOMES;

D O I：

10.1136/bmj.b441

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 12 条

[1] Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J].

Chaturvedi, N ;

Sjolie, AK ;

Stephenson, JM ;

Abrahamian, H ;

Keipes, M ;

Castellarin, A ;

Rogulja-Pepeonik, Z ;

Fuller, JH .

LANCET, 1998, 351 (9095) :28-31

[2] Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials [J].

Chaturvedi, Nish ;

Porta, Massimo ;

Klein, Ronald ;

Orchard, Trevor ;

Fuller, John ;

Parving, Hans Henrik ;

Bilous, Rudy ;

Sjolie, Anne Katrin .

LANCET, 2008, 372 (9647) :1394-1402

[3]

Diabet Control Complications Trial Res Grp, 1995, OPHTHALMOLOGY, V102, P647

[4]

Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743

[5] Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial [J].

Keech, A. C. ;

Mitchell, P. ;

Summonen, P. A. ;

O'Day, J. ;

Davis, T. M. E. ;

Moffitt, M. S. ;

Taskinen, M. R. ;

Simes, R. J. ;

Tse, D. ;

Williamson, E. ;

Merrifield, A. ;

Laatikainen, L. T. ;

d'Emden, M. C. ;

Crimet, D. C. ;

O'Connell, R. L. ;

Colman, P. G. .

LANCET, 2007, 370 (9600) :1687-1697

[6] Management of diabetic retinopathy - A systematic review [J].

Mohamed, Quresh ;

Gillies, Mark C. ;

Wong, Tien Y. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (08) :902-916

[7] Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial [J].

Patel, A. ;

MacMahon, S. ;

Chalmers, J. ;

Neal, B. ;

Woodward, M. ;

Billot, L. ;

Harrap, S. ;

Poulter, N. ;

Marre, M. ;

Cooper, M. ;

Glasziou, P. ;

Grobbee, D. E. ;

Hamet, P. ;

Heller, S. ;

Liu, L. S. ;

Mancia, G. ;

Mogensen, C. E. ;

Pan, C. Y. ;

Rodgers, A. ;

Williams, B. .

LANCET, 2007, 370 (9590) :829-840

[8] Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes [J].

Patel, Anushka ;

MacMahon, Stephen ;

Chalmers, John ;

Neal, Bruce ;

Billot, Laurent ;

Woodward, Mark ;

Marre, Michel ;

Cooper, Mark ;

Glasziou, Paul ;

Grobbee, Diederick ;

Hamet, Pavel ;

Harrap, Stephen ;

Heller, Simon ;

Liu, Lisheng ;

Mancia, Giuseppe ;

Mogensen, Carl Erik ;

Pan, Changyu ;

Poulter, Neil ;

Rodgers, Anthony ;

Williams, Bryan ;

Bompoint, Severine ;

de Galan, Bastiaan E. ;

Joshi, Rohina ;

Travert, Florence .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) :2560-2572

[9] Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial [J].

Sjolie, Anne Katrin ;

Klein, Ronald ;

Porta, Massimo ;

Orchard, Trevor ;

Fuller, John ;

Parving, Hans Henrik ;

Bilous, Rudy ;

Chaturvedi, Nish .

LANCET, 2008, 372 (9647) :1385-1393

[10]

Stearne MR, 1998, BMJ-BRIT MED J, V317, P703

← 1 2 →